Pharmacy weighs business impact on non-NHI reimbursement of combined drug

Published: 2006-08-01 06:59:00

Updated: 2006-08-01 06:59:00

Recently the government announced that 742 combined drugs turned to the non-NHI reimbursement schedule, for which the pharmacy circles took an attitude of a half positive with other half negative, expecting that in one way or others the transfer of 742 drugs to the non-NHI reimbursement schedule ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK